Viktoria Havasi
Overview
Explore the profile of Viktoria Havasi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
279
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Siddiqui A, Saxena A, Echols J, Havasi V, Fu L, Keeling K
Heliyon
. 2023 Dec;
9(11):e22281.
PMID: 38045134
Background: nonsense alleles generate negligible CFTR protein due to the nonsense mutation: 1) triggering mRNA degradation by nonsense-mediated mRNA decay (NMD), and 2) terminating mRNA translation prematurely. Thus, people with...
2.
Echols J, Siddiqui A, Dai Y, Havasi V, Sun R, Kaczmarczyk A, et al.
Dis Model Mech
. 2020 Aug;
13(8).
PMID: 32737261
Nonsense-mediated mRNA decay (NMD) targets mRNAs that contain a premature termination codon (PTC) for degradation, preventing their translation. By altering the expression of PTC-containing mRNAs, NMD modulates the inheritance pattern...
3.
Stalvey M, Havasi V, Tuggle K, Wang D, Birket S, Rowe S, et al.
PLoS One
. 2017 Dec;
12(11):e0188497.
PMID: 29190650
Background: Reduced growth and osteopenia are common in individuals with cystic fibrosis (CF). Additionally, improved weight and height are associated with better lung function and overall health in the disease....
4.
Chung W, Goeckeler-Fried J, Havasi V, Chiang A, Rowe S, Plyler Z, et al.
PLoS One
. 2016 Oct;
11(10):e0163615.
PMID: 27732613
Small molecules that correct the folding defects and enhance surface localization of the F508del mutation in the Cystic Fibrosis Transmembrane conductance Regulator (CFTR) comprise an important therapeutic strategy for cystic...
5.
6.
Stalvey M, Clines K, Havasi V, McKibbin C, Dunn L, Chung W, et al.
PLoS One
. 2013 Nov;
8(11):e80098.
PMID: 24236172
Low bone mass and increased fracture risk are recognized complications of cystic fibrosis (CF). CF-related bone disease (CFBD) is characterized by uncoupled bone turnover--impaired osteoblastic bone formation and enhanced osteoclastic...
7.
Lazrak A, Fu L, Bali V, Bartoszewski R, Rab A, Havasi V, et al.
FASEB J
. 2013 Aug;
27(11):4630-45.
PMID: 23907436
The most common disease-causing mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene is the out-of-frame deletion of 3 nucleotides (CTT). This mutation leads to the loss of phenylalanine-508...
8.
Havasi V, Rowe S, Kolettis P, Dayangac D, Sahin A, Grangeia A, et al.
Fertil Steril
. 2010 Jan;
94(6):2122-7.
PMID: 20100616
Objective: To investigate whether genetic modifiers of cystic fibrosis (CF) lung disease also predispose to congenital bilateral absence of the vas deferens (CBAVD) in association with cystic fibrosis transmembrane conductance...
9.
Banyai K, Gentsch J, Martella V, Bogdan A, Havasi V, Kisfali P, et al.
J Infect Dis
. 2009 Oct;
200 Suppl 1:S222-7.
PMID: 19821713
Epidemiological trends of the globally most common rotavirus genotype, G1P[8], were investigated in Hungary during a 16-year period by sequencing and phylogenetic analysis of the surface antigens. Antigen shift among...
10.
Havasi V, Keiles S, Hambuch T, Sorscher E, Kammesheidt A
Genet Med
. 2008 Dec;
10(12):910-4.
PMID: 19092444
Purpose: Congenital bilateral absence of the vas deferens is a pathologic condition associated with normal spermatogenesis, azoospermia, and lack of both vasa deferentia. A significant association between mutations in the...